Norditropin (Novo Nordisk)


Welcome to the PulseAid listing for the Norditropin drug offered from Novo Nordisk. This Recombinant Human Growth Hormone [EPC],Recombinant Human Growth Hormones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Novo Nordisk
NON-PROPRIETARY NAME: somatropin
SUBSTANCE NAME: SOMATROPIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Recombinant Human Growth Hormone [EPC],Recombinant Human Growth Hormones [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-03-30
END MARKETING DATE: 0000-00-00


Norditropin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNorditropin from Novo Nordisk
LABELER NAME: Novo Nordisk
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/3mL)
START MARKETING DATE: 2009-03-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0169-7703_c8b18e24-9ddd-4a1f-bfd0-ccaa7c00622d
PRODUCT NDC: 0169-7703
APPLICATION NUMBER: NDA021148

Other SOMATROPIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnuMed International LLCe-HGH
Genentech, Inc.Nutropin AQ NuSpin 10
Novo NordiskNorditropin
Physicians Total Care, Inc.Norditropin
Sandoz IncOmnitrope